Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2022 | Unmet needs in pediatric HSCT

Simone Cesaro, MD, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy, describes current challenges in pediatric hematopoietic stem cell transplantation (HSCT), including the late approval of new treatments. Dr Cesaro highlights the need to efficiently indicate novel drugs in a pediatric setting so that these patients can receive quality care in an expedient manner. This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.